Lindsey A Herrel1, John D Syrjamaki1, Susan M Linsell2, David C Miller1, James M Dupree3. 1. Dow Division of Urological Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI; Michigan Value Collaborative, Ann Arbor, MI. 2. Dow Division of Urological Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI. 3. Dow Division of Urological Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI; Michigan Value Collaborative, Ann Arbor, MI. Electronic address: jmdupree@med.umich.edu.
Abstract
OBJECTIVE: To describe total and component radical prostatectomy (RP) episode costs across a diverse set of hospitals in Michigan, and examine drivers of variation in such payments. METHODS: We identified Medicare and private payer patients undergoing RP from 2012 to 2014 from the claims-based registry maintained by the Michigan Value Collaborative, a statewide consortium that provides hospitals with price-standardized and risk-adjusted 90-day episode costs for common medical and surgical procedures. We divided hospitals into quartiles based on mean total episode cost for RP. Total episode costs were further classified into 4 payment categories: index hospitalization, professional services, readmissions, and postacute care. Component payments were then compared across high-cost and low-cost hospitals. RESULTS: We identified 3077 patients undergoing RP in 42 hospitals. Mean 90-day total episode cost was $14,614, ranging from $13,043 to $16,749 across quartiles (28.4% difference, P < .001). Overall variation in total episode cost was divided nearly equally among readmissions (29%), postacute care (29%), and professional payments (26%). We noted significantly higher readmission ($1442 vs $288, P = .03) and postacute care payments at high-cost hospitals ($1686 vs $522, P = .002). CONCLUSION: Significant variation exists in 90-day total episode costs for RP, suggesting a potential target for bundled payments and other care improvement efforts. Focused efforts on reducing variation in readmissions and postacute care could improve cost-efficiency.
OBJECTIVE: To describe total and component radical prostatectomy (RP) episode costs across a diverse set of hospitals in Michigan, and examine drivers of variation in such payments. METHODS: We identified Medicare and private payer patients undergoing RP from 2012 to 2014 from the claims-based registry maintained by the Michigan Value Collaborative, a statewide consortium that provides hospitals with price-standardized and risk-adjusted 90-day episode costs for common medical and surgical procedures. We divided hospitals into quartiles based on mean total episode cost for RP. Total episode costs were further classified into 4 payment categories: index hospitalization, professional services, readmissions, and postacute care. Component payments were then compared across high-cost and low-cost hospitals. RESULTS: We identified 3077 patients undergoing RP in 42 hospitals. Mean 90-day total episode cost was $14,614, ranging from $13,043 to $16,749 across quartiles (28.4% difference, P < .001). Overall variation in total episode cost was divided nearly equally among readmissions (29%), postacute care (29%), and professional payments (26%). We noted significantly higher readmission ($1442 vs $288, P = .03) and postacute care payments at high-cost hospitals ($1686 vs $522, P = .002). CONCLUSION: Significant variation exists in 90-day total episode costs for RP, suggesting a potential target for bundled payments and other care improvement efforts. Focused efforts on reducing variation in readmissions and postacute care could improve cost-efficiency.
Authors: Daniel M Alyesh; Milan Seth; David C Miller; James M Dupree; John Syrjamaki; Devraj Sukul; Simon Dixon; Eve A Kerr; Hitinder S Gurm; Brahmajee K Nallamothu Journal: Circ Cardiovasc Qual Outcomes Date: 2018-06
Authors: Vinay Guduguntla; John D Syrjamaki; Chad Ellimoottil; David C Miller; Richard L Prager; Edward C Norton; Patricia Theurer; Donald S Likosky; James M Dupree Journal: JAMA Surg Date: 2018-01-01 Impact factor: 14.766
Authors: Chad Tang; Xiudong Lei; Grace L Smith; Hubert Y Pan; Kenneth Hess; Aileen Chen; Karen E Hoffman; Brian F Chapin; Deborah A Kuban; Mitchell Anscher; Ya-Chen Tina Shih; Steven J Frank; Benjamin D Smith Journal: Pract Radiat Oncol Date: 2020-04-13
Authors: Devraj Sukul; Milan Seth; James M Dupree; John D Syrjamaki; Andrew M Ryan; Brahmajee K Nallamothu; Hitinder S Gurm Journal: Circ Cardiovasc Interv Date: 2019-01 Impact factor: 6.546
Authors: Deborah R Kaye; John Syrjamaki; Chad Ellimoottil; Edward W Schervish; M Hugh Solomon; Susan Linsell; James E Montie; David C Miller; James M Dupree Journal: Urology Date: 2017-11-16 Impact factor: 2.649
Authors: Chris Song; Devraj Sukul; Milan Seth; David Wohns; Simon R Dixon; Nicklaus K Slocum; Hitinder S Gurm Journal: Circ Cardiovasc Interv Date: 2018-06 Impact factor: 6.546
Authors: Chris Song; Devraj Sukul; Milan Seth; James M Dupree; Akshay Khandelwal; Simon R Dixon; David Wohns; Thomas LaLonde; Hitinder S Gurm Journal: Am J Cardiol Date: 2017-08-30 Impact factor: 2.778